Macquarie Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Macquarie Group’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-400	Closed	-$42K	–	2414
2017 Q4	$42K	Hold	400	–	–	﹤0.01%	2021
2017 Q3	$45K	Hold	400	–	–	﹤0.01%	2016
2017 Q2	$45K	Hold	400	–	–	﹤0.01%	1486
2017 Q1	$47K	Hold	400	–	–	﹤0.01%	1505
2016 Q4	$42K	Buy	+400	New	+$41.9K	﹤0.01%	1508
2015 Q4	–	Sell	-18,954	Closed	-$2.71M	–	1565
2015 Q3	$2.71M	Buy	18,954 +7,261	+62%	+$1.02M	0.01%	898
2015 Q2	$1.68M	Buy	11,693 +5,131	+78%	+$732K	﹤0.01%	1071
2015 Q1	$925K	Buy	+6,562	New	+$1.01M	﹤0.01%	1171

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group's TARO Position: Q1 2018 in Review

Macquarie Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2018, closing a stake of 400 shares — an estimated $42K sold.

Macquarie Group first reported a position in TARO in Q1 2015 and held it in 8 quarters. The position peaked at $2.71M in Q3 2015. 109 funds tracked by Wall St. Rank hold TARO as of Q1 2018.

Macquarie Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2018 after selling out during the quarter.
Macquarie Group sold 400 Taro Pharmaceutical Industries Ltd. shares in Q1 2018, an estimated $42K.
Macquarie Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2015 and held it in 8 quarters.
Macquarie Group's Taro Pharmaceutical Industries Ltd. position peaked at $2.71M in Q3 2015.
109 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2018.

Based on Macquarie Group's 13F filing for Q1 2018, filed 11 May 2018.